Follow the Newbury Pharmaceuticals AB stock price and the full management transaction log of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Newbury Pharmaceuticals AB has published 3 insider filings. Market capitalisation: €76m. The latest transaction was disclosed on 18 November 2025 (Purchase). Among the most active insiders: Alsakali Equity AB. All data is accessible without an account.
3
Insider Decl.
n/a
Thresholds
€13,711
3 ops.
Buy Volume
n/a
n/a
Sell Volume
33Σ signal
Buys €13,711n/a Sells
Fundamental score
Ranked 27,306 of 29,064 companies
17.2
score / 100
Value
11
Quality
23
FCF yld-18%
Earn yld-19%
EV/EBITDA·
ROE-67%
Gross mgn44%
Net mgn-42%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.